Improvement in the anemia of chronic renal failure with fluoxymesterone.
D000741:Anemia, Aplastic / Q000188:drug therapy / Q000209:etiology*; D001777:Blood Coagulation; D001803:Blood Transfusion; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000096:biosynthesis*; D005260:Female; D005474:Fluoxymesterone / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000097:blood; D007503:Iron Isotopes; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000150:complications*; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008134:Long-Term Care; D008297:Male; D011517:Prothrombin Time; D014859:Warfarin / Q000009:adverse effects
D007503:Iron Isotopes; D004921:Erythropoietin; D014859:Warfarin; D005474:Fluoxymesterone; D007501:Iron